# Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery

> **NCT02295124** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 200 (actual)

## Conditions studied

- Nausea

## Interventions

- **DRUG:** Oxycodone
- **DRUG:** Hydromorphone

## Key facts

- **NCT ID:** NCT02295124
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02295124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02295124, "Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02295124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*